Mindray Medical International (MR) Tops Q1 EPS by 2c

Mindray Medical International (NYSE: MR) reported Q1 EPS of $0.39, $0.02 better than the analyst estimate of $0.37. Revenue for the quarter came in at $264.8 million versus the consensus estimate of $292.5 million.

For earnings history and earnings-related data on Mindray Medical International (MR) click here.

You May Also Be Interested In

• Jefferies sees a buying opportunity in this S&P 500 sector
• Benchmark Reiterates Buy Rating on NANO Nuclear Energy (NNE)
• PSQ Holdings closes $1.3M private placement with board participation